Spectral Medical Stock Forecast, Price & News

0.00 (-0.48 %)
(As of 06/15/2021 01:47 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume2,000 shs
Average Volume30,509 shs
Market Capitalization$91.22 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive EDTXF News and Ratings via Email

Sign-up to receive the latest news and ratings for Spectral Medical and its competitors with MarketBeat's FREE daily newsletter.

Spectral Medical logo

About Spectral Medical

Spectral Medical Inc. focuses on the development and commercialization of products for the treatment of septic shock and renal disease in North America. The company markets Endotoxin Activity Assay, a rapid in vitro diagnostic test for the detection of components of gram negative bacterial cell wall; and Polymyxin B Hemoperfusion, a therapeutic hemoperfusion device that removes endotoxin from the bloodstream. It also develops and manufactures monoclonal and polyclonal antibodies, recombinant cardiac proteins, and calibrators for use in the research and development, as well as products that are manufactured by other diagnostic companies; and develops platform for renal replacement therapy. The company was formerly known as Spectral Diagnostics Inc. and changed its name to Spectral Medical Inc. in December 2014. Spectral Medical Inc. was founded in 1991 and is headquartered in Toronto, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.56 out of 5 stars

Medical Sector

1496th out of 2,100 stocks

Surgical & Medical Instruments Industry

136th out of 174 stocks

Analyst Opinion: 0.0Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Spectral Medical (OTCMKTS:EDTXF) Frequently Asked Questions

What stocks does MarketBeat like better than Spectral Medical?

Wall Street analysts have given Spectral Medical a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Spectral Medical wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Spectral Medical's next earnings date?

Spectral Medical is scheduled to release its next quarterly earnings announcement on Friday, August 13th 2021.
View our earnings forecast for Spectral Medical

How were Spectral Medical's earnings last quarter?

Spectral Medical Inc. (OTCMKTS:EDTXF) posted its earnings results on Friday, March, 26th. The company reported ($0.01) EPS for the quarter. The firm had revenue of $0.41 million for the quarter. Spectral Medical had a negative net margin of 328.22% and a negative trailing twelve-month return on equity of 920.56%.
View Spectral Medical's earnings history

How has Spectral Medical's stock been impacted by COVID-19?

Spectral Medical's stock was trading at $0.3884 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, EDTXF shares have decreased by 3.8% and is now trading at $0.3736.
View which stocks have been most impacted by COVID-19

Who are Spectral Medical's key executives?

Spectral Medical's management team includes the following people:
  • Mr. Christopher Seto, CEO, CFO & COO
  • Dr. Gualtiero Guadagni, VP of Sales & Marketing
  • Ms. Debra-Anne M. Foster B.Sc., RN, CCRC, VP of Clinical Devel.
  • Dr. John A. Kellum M.D., Chief Medical Officer

Who are some of Spectral Medical's key competitors?

What is Spectral Medical's stock symbol?

Spectral Medical trades on the OTCMKTS under the ticker symbol "EDTXF."

How do I buy shares of Spectral Medical?

Shares of EDTXF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Spectral Medical's stock price today?

One share of EDTXF stock can currently be purchased for approximately $0.37.

How much money does Spectral Medical make?

Spectral Medical has a market capitalization of $91.22 million and generates $1.57 million in revenue each year.

How many employees does Spectral Medical have?

Spectral Medical employs 29 workers across the globe.

What is Spectral Medical's official website?

The official website for Spectral Medical is www.spectraldx.com.

Where are Spectral Medical's headquarters?

Spectral Medical is headquartered at 135 The West Mall Unit 2, Toronto A6, M9C 1C2.

How can I contact Spectral Medical?

Spectral Medical's mailing address is 135 The West Mall Unit 2, Toronto A6, M9C 1C2. The company can be reached via phone at (416) 626-3233 or via email at [email protected]

This page was last updated on 6/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.